Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril for prevention of early atrial fibrillation recurrence after pulmonary vein isolation
ChiCTR-TRC-14004841Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of perindopril in Atrial fibrillation (AFib) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Recurrence of atrial fibrillation. Started Mar 2013; status: completed.
02
Drugs
perindopril
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR-TRC-14004841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004841.